

SpaceX's blowout third quarter and Super Micro's guidance hike revive the AI trade, lifting the Nasdaq 100 as Netflix and AT&T slide on results.
You can purchase shares of Medpace Holdings (NASDAQ:MEDP) through any online brokerage.
Other companies in Medpace Holdings’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Medpace Holdings has a consensus price target of $555.75.
The stock price for Medpace Holdings (NASDAQ: MEDP) is $673.79 last updated October 27, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Medpace Holdings.
Medpace Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Medpace Holdings.
Medpace Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including...